advanced search

Welcome: Guest

log in

China Medical Technologies, Inc. Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 51
ISBN Number not applicable
Product Code GMD04766
Price

£490.00
approximately: $749 | €546

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a China Medical Technologies, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1.1 List Of Tables
  • 1.2 List of Figures
  • 2 Company Overview
  • 2.1 Key Information
  • 2.2 Industry Outlook In Vitro Diagnostics
  • 3 Major Products and Services
  • 3.1 Overview
  • 4 Competitors
  • 5 Key Employees
  • 6 Locations And Subsidiaries
  • 6.1 Head Office
  • 7 Recent Developments
  • 7.1 Financial Announcements
    • 7.1.1 Aug 04, 2008: China Medical Reports 1Q Fiscal 2008 Results
    • 7.1.2 Jun 12, 2008: China Medical Declares Cash Dividend
    • 7.1.3 Jun 12, 2008: China Medical Declares Q4 Fiscal 2007 Results
    • 7.1.4 Apr 11, 2008: China Medical To Declare Q4 2007 Results
    • 7.1.5 Feb 28, 2008: China Medical Declares Q3 Fiscal 2007 Results
    • 7.1.6 Nov 20, 2007: China Medical Declares Q2 Fiscal 2007 Results
    • 7.1.7 Aug 28, 2007: China Medical Declares Q1 Fiscal 2007 Results
    • 7.1.8 Jun 18, 2007: China Medical Declares Cash Dividend
    • 7.1.9 Jun 18, 2007: China Medical Declares Q4 Fiscal 2006 Results
  • 7.2 Corporate Communications
    • 7.2.1 Jun 18, 2007: China Medical Appoints New Board Member
  • 7.3 Product News
    • 7.3.1 Apr 03, 2008: China Medical Technologies Completed The Development Of Prostate Cancer FISH Reagent
    • 7.3.2 Mar 24, 2008: China Medical Technologies Announces CE Approval For JETLIA-96/2
    • 7.3.3 Mar 24, 2008: China Medical Technologies Receives CE Mark For MPC-1 Analyzer
    • 7.3.4 Jul 16, 2007: FDA Agrees To Conditional Approval Of China Medical Technologies' Investigational Device Exemption Application
  • 7.4 Product Approvals
    • 7.4.1 Mar 24, 2008: China Medical Technologies Receives CE Mark For MPC-1 Analyzer
    • 7.4.2 Mar 24, 2008: China Medical Technologies Announces CE Approval For JETLIA-96/2
    • 7.4.3 Jul 16, 2007: FDA Agrees To Conditional Approval Of China Medical Technologies' Investigational Device Exemption Application
  • 7.5 Other Significant Developments
    • 7.5.1 Nov 19, 2007: China Medical Announces Board And Management Changes
  • 8 China Medical Technologies, Inc. Pipeline Products
  • 8.1 China Medical Technologies, Inc. Product Pipeline Analysis
    • 8.1.1 China Medical Technologies, Inc. Pipeline Products By Equipment Type
    • 8.1.2 China Medical Technologies, Inc. Pipeline Products By Development Stage
    • 8.1.3 China Medical Technologies, Inc. Pipeline Products By Therapy Area
    • 8.1.4 China Medical Technologies, Inc. Pipeline Products By Clinical Trials
    • 8.1.5 China Medical Technologies, Inc. Pipeline Products By News Summary
  • 8.2 HIFU tumor therapy system
    • 8.2.1 Product Description
    • 8.2.2 Product Status
    • 8.2.3 Clinical Trials
    • 8.2.4 Product Milestone
  • 8.3 Myoglobin-Cardiac Marker
    • 8.3.1 Product Description
    • 8.3.2 Product Status
  • 8.4 CK-MB (Creatine Kinase-MB)
    • 8.4.1 Product Description
    • 8.4.2 Product Status
  • 8.5 cTnI (Cardiac Troponin I)
    • 8.5.1 Product Description
    • 8.5.2 Product Status
  • 8.6 HCVA (Antibodies to Hepatitis C)
    • 8.6.1 Product Description
    • 8.6.2 Product Status
  • 8.7 FABP (Fatty Acid Binding Protein)
    • 8.7.1 Product Description
    • 8.7.2 Product Status
  • 8.8 AUTOLIA-12/48
    • 8.8.1 Product Description
    • 8.8.2 Product Status
  • 8.9 CRP (C-Reactive Protein)
    • 8.9.1 Product Description
    • 8.9.2 Product Status
  • 8.10 UALB (Urea Albumin)
    • 8.10.1 Product Description
    • 8.10.2 Product Status
  • 8.11 a1-MG
    • 8.11.1 Product Description
    • 8.11.2 Product Status
  • 8.12 2-MG (2-Microglbulin)
    • 8.12.1 Product Description
    • 8.12.2 Product Status
  • 8.13 N-hANP (N-Terminal-Human)
    • 8.13.1 Product Description
    • 8.13.2 Product Status
  • 8.14 HIV test
    • 8.14.1 Product Description
    • 8.14.2 Product Status
  • 8.15 P24 (Protein 24)
    • 8.15.1 Product Description
    • 8.15.2 Product Status
  • 8.16 tIgE (Total IgE)
    • 8.16.1 Product Description
    • 8.16.2 Product Status
  • 8.17 Prostate Cancer FISH Detection Kit
    • 8.17.1 Product Description
    • 8.17.2 Product Status
    • 8.17.3 Product Milestone
  • 9 Appendix
  • 9.1 Methodology
    • 9.1.1 Coverage
    • 9.1.2 Secondary Research
    • 9.1.3 Primary Research
    • 9.1.4 Expert Panel Validation
  • 9.2 Contact Us
  • 9.3 About Global Markets Direct
  • 9.4 Disclaimer
  • 1 List of Tables
  • Table 1: China Medical Technologies, Inc.,Key Facts
  • Table 2: China Medical Technologies, Inc., Key Employees,
  • Table 3: China Medical Technologies, Inc. Pipeline Products by Equipment Type
  • Table 4: China Medical Technologies, Inc. Pipeline Products By Development Stage
  • Table 5: China Medical Technologies, Inc. Pipeline Products By Therapy Area
  • Table 6: China Medical Technologies, Inc. Pipeline Products By Clinical Trials
  • Table 7: China Medical Technologies, Inc. Pipeline Products By News Summaries
  • 1.2 List of Figures
  • Figure 1: China Medical Technologies, Inc. Pipeline Products By Equipment Type
  • Figure 2: China Medical Technologies, Inc. Pipeline Products By Equipment Type
  • Figure 3: China Medical Technologies, Inc. Pipeline Products By Development Stage
  • Figure 4: Global Markets Direct Methodology